The North America urinalysis market is projected to grow from $1,650 million in 2020 to $3,450 million by 2035, at a CAGR of 6.2%. Consistent growth is attributed to the rising burden of chronic diseases, persistent technological advancements, and expanding adoption in both clinical and point-of-care settings. The period between 2025 and 2030 anticipates the fastest revenue acceleration, coinciding with widespread laboratory automation and broader reimbursement coverage for advanced diagnostic solutions. As healthcare infrastructure continues to modernize, demand for efficient and high-throughput urinalysis platforms will drive further market expansion.
Read More - https://bussinessinsights.com/research-report/north-america-urinalysis-market
Disease screening leads the application segment in the North America urinalysis market, reflecting the high prioritization of early detection protocols in healthcare systems. Pregnancy and fertility testing maintains significant demand due to ongoing advancements in reproductive health diagnostics. Drug testing remains a key segment, spurred by regulatory mandates and workplace health programs. The market also benefits from continued adoption in diabetes screening, kidney disease diagnostics, and UTI detection. This diverse application base, coupled with the proliferation of both clinical and point-of-care urinalysis, supports the upward revenue trajectory of the sector. Companies are developing multiplexed and integrated testing solutions to broaden clinical utility and operational efficiency.
Request Free Sample- https://bussinessinsights.com/request/healthcare/north-america-urinalysis-market
Who are the key players in North America Urinalysis Market industry?
The top five players in the North America Urinalysis Market are Siemens Healthineers, Abbott Laboratories, F. Hoffmann-La Roche AG, Beckman Coulter (Danaher Corporation), and Sysmex Corporation. These companies lead the market with extensive diagnostic portfolios, advanced technology, and a strong geographic presence, driving innovation in urinalysis solutions.
What is the North America Urinalysis Market growth?
The North America Urinalysis Market is experiencing steady growth, estimated at a CAGR of over 7% from 2023–2028. Recent advancements, such as Abbott’s launch of next-generation urinalysis analyzers, and increased demand for automated diagnostic systems, are driving expansion and market penetration across healthcare settings.
Which segment accounted for the largest North America Urinalysis Market share?
The diagnostic laboratories segment holds the largest market share in the North America Urinalysis Market. This is due to the high volume of routine urinalysis tests performed in labs, increasing chronic disease cases, and adoption of automated systems that improve accuracy and workflow in clinical diagnostics.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com